Today, Colin Cieszynski and The Panic-Proof Portfolio (Stockchase Research) commented about whether PKI-T, KEG.UN-T, TD-T, BMO-T, PYPL-Q, LNG-A, MRC-T, DOL-T, GM-N, AAPL-Q, ATS-T, ENB-T, HBM-T, JNJ-N, BNS-T, CJT-T, AC-T, NTR-T, BBD.B-T, CVNA-N, LLY-N, ATH-T, NVDA-Q, TLT-Q, CP-T, C-N, ATD-T, CSU-T, CLS-T, NVDA-Q, MU-Q, TM-N, ARE-T are stocks to buy or sell.
Huge rally. Has now come down in RSI ranking, along with other metal producers. So far, looks like a correction within an uptrend, holding above the early May low of $11-11.50. Last couple of days, price of copper has started to pick back up again, starting to stabilize, and may see stocks do the same.
We've had one rate cut, but investors are likely waiting to see how many more there will be in the near term. Just one or two, or a prolonged campaign of cuts? And people don't know yet, especially since half the central banks have cut and half haven't. So they're waiting for more confirmation before they get more conviction on those names.
Struggling. The best we can say is that the chart seems finally to be stabilizing. Hard to say whether it needs a washout before the downtrend is over. Trying to bottom, but hasn't picked up yet.
When you ask yourself what could happen, technicians look at a 50% retracement, where a stock would give up half of the move. So, if you went from $15 to $60, that's a $45 gain. Half of that is $22.50. The high of $60 - $22.50 brings you to $37.50, which is close to the 2022 lows.
Underperforming on RSI. Not that it was going down, but was going sideways when everything else was going up. Blasted above $195 and has moved into the top zone in relative strength. That big break out suggests more buying, even though talk this week is about rebalancing for less AAPL and more NVDA. Has held up nicely above $200 and rising within the RSI ranking. Yield is 0.47%.
(Analysts’ price target is $208.32)Canadian growth story that's outperformed. Steady, long-term accumulation and consistent growth, which is very strong technically. A bit of a correction, but still holding nicely above $120. The discount retailers have been doing well, and if we see a retrenchment in consumer spending as we've been seeing in recent months, these are stocks that could benefit. Yield is 0.30%.
(Analysts’ price target is $130.25)Certainly a possibility. Seasonally, June historically has been a softer month for markets, and then historically July sees a bit of a bounce. From the middle of August and the end of earnings season to mid-October is usually the weakest and most volatile time of the year for equities. We're in a US election year, which could also add to volatility and uncertainty.
Markets are still looking good. Some areas are a lot stronger than others, and we're heading into a season that's traditionally more volatile.
So far, so good, where the 4th year of a presidency heading into an election is strong for markets. So far this year has been similar to 2012, when Obama and Biden ran for re-election. At that point, markets did a 1/4 pause and 1/4 negative, alternating. And this is what we've seen over the last number of months.
US drug stocks struggling, the sector has significantly weakened RSI. Can see this in JNJ chart, retesting 52-week lows, seeing lower highs. $144 is a pretty significant support level, and it's bounced off 4x already. If it bounces again, encouraging and strong support; taken out, could be really disappointing.